June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Use of a handheld electrophysiology device (RETeval, LKC) to identify visual pathway decussation defects
Author Affiliations & Notes
  • Eloise Keeling
    University of Southampton, Southampton, Hampshire, United Kingdom
  • Perry Carter
    University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
  • Fatima Shawkat
    University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
  • Helena Lee
    University of Southampton, Southampton, Hampshire, United Kingdom
    University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
  • James Self
    University of Southampton, Southampton, Hampshire, United Kingdom
    University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
  • Footnotes
    Commercial Relationships   Eloise Keeling None; Perry Carter None; Fatima Shawkat None; Helena Lee None; James Self None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5325. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eloise Keeling, Perry Carter, Fatima Shawkat, Helena Lee, James Self; Use of a handheld electrophysiology device (RETeval, LKC) to identify visual pathway decussation defects. Invest. Ophthalmol. Vis. Sci. 2023;64(8):5325.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Electrodiagnostic testing (EDTs) require large equipment and trained clinical scientists so are restricted to specialist centres, and often have long waiting lists. Pattern and flash visual evoked potentials (fVEP) have been utilised in the assessment of visual pathway integrity, including chiasmal anomalies in albinism. In this qualitative clinical study, we assess the potential of the handheld RETeval to screen for excess nerve decussation and other post-chiasmal defects.

Methods : 18 patients with suspected albinism or retro-chiasmal lesions (aged 0-15yrs, mean 5) were selected from those undergoing routine EDTs at a regional referral centre. Standard paediatric EDTs were performed, followed by fVEP using the RETeval. Control data was collected from 12 volunteers (aged 26-54yrs, mean 32). Right and left occipital electrodes were placed midway between Oz (10-20 system) and either ear. The ground electrode was placed at Fz. FVEPs of 3cd.s/m2 were recorded from 10 brief (<5ms) 1Hz flashes. The left occipital VEP waveform was subtracted from that of the right occiput, creating a single channel response for each eye separately. RETeval data was compared to results obtained from the standard paediatric protocol using a photic stimulator (Grass PS 22). Pearson’s correlation was used to calculate the extent of asymmetry, where a value of -1 showed complete asymmetry whilst a value of +1 showed absolute symmetry in occipital VEP distribution. Data between controls and patients were compared using a Mann-Whitney U test.

Results : FVEP testing using both the standard protocol and the RETeval identified asymmetry in 11 patients with suspected albinism. The Pearsons correlate of the albinism cohort (-0.504 ± 0.208) was compared to the control data (0.184 ± 0.339) and a Mann-Whitney U test showed a significant difference between the two groups (p<0.001). This demonstrates the effectiveness of the RETeval in detecting crossed asymmetry secondary to excessive nerve decussation in albinism. The RETeval also detected 7 cases of left and right retro-chiasmal lesions that showed an uncrossed asymmetry.

Conclusions : This study adds to the growing body of work investigating the use of the handheld RETeval device for prioritising patients waiting for in-depth EDTs. This data shows the RETeval has the potential to be used as a screening tool for the detection of chiasmal and retro-chiasmal anomalies.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×